The tweet was deleted by the author.
But we saved everything 🙂.
Nautilus Biotechnology has announced Baylor College of Medicine as the inaugural customer for its Iterative Mapping Early Access Program.
Under a research initiative led by professors Bing Zhang, Ph.D. and Yongchao Dou, Ph.D., Baylor researchers will use the Nautilus Voyager Platform to tackle complex scientific questions. The collaboration is positioned to advance early-stage applications of Nautilus Biotechnology’s proteomics technology.
The Baylor collaboration marks another significant milestone as Nautilus Biotechnology extends the reach of its proteomics technology. Recent developments build upon the company’s earlier focus, including the high-profile engagement with US HUPO President-Elect Olga Vitek on advancing statistical rigor in proteomics research, as detailed in Nautilus Biotechnology’s proteomics episode. This momentum also follows strategic leadership appointments designed to accelerate commercial growth, such as the selection of Amber Faust as Vice President of Sales to drive proteomics expansion.